Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults. - Wikidata - wikimedia - TriplyDB

Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults.

Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults.

http://www.wikidata.org/entity/Q37146495

about

Toxicity of amphetamines: an update The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study Disposition of MDMA and metabolites in human sweat following controlled MDMA administration Lost in translation: preclinical studies on 3,4-methylenedioxymethamphetamine provide information on mechanisms of action, but do not allow accurate prediction of adverse events in humans Clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"): the influence of gender and genetics (CYP2D6, COMT, 5-HTT)Critical role of peripheral vasoconstriction in fatal brain hyperthermia induced by MDMA (Ecstasy) under conditions that mimic human drug use The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), methamphetamine and D-amphetamine.Mice lacking multidrug resistance protein 1a show altered dopaminergic responses to methylenedioxymethamphetamine (MDMA) in striatum Effect of 3,4-methylenedioxymethamphetamine on the toxicokinetics and sedative effects of the drug of abuse, γ-hydroxybutyric acid.Effects of 3,4-methylenedioxymethamphetamine (MDMA) and its main metabolites on cardiovascular function in conscious rats.The effect of acutely administered MDMA on subjective and BOLD-fMRI responses to favourite and worst autobiographical memories.The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers.Baths salts, spice, and related designer drugs: the science behind the headlines.Metabolism and disposition of 3,4-methylenedioxymethamphetamine ("ecstasy") in baboons after oral administration: comparison with humans reveals marked differences.Ecstasy use and suicidal behavior among adolescents: findings from a national survey Urinary MDMA, MDA, HMMA, and HMA excretion following controlled MDMA administration to humans.Direct comparison of (+/-) 3,4-methylenedioxymethamphetamine ("ecstasy") disposition and metabolism in squirrel monkeys and humans.MDMA and metabolite disposition in expectorated oral fluid after controlled oral MDMA administration.Development of a high-speed MALDI-triple quadrupole mass spectrometric method for the determination of 3,4-methylenedioxymethamphetamine (MDMA) in oral fluid.Effects of MDMA and related analogs on plasma 5-HT: relevance to 5-HT transporters in blood and brain.3,4-Methylenedioxymethamphetamine (MDMA) and metabolites disposition in blood and plasma following controlled oral administration.Oral fluid and plasma 3,4-methylenedioxymethamphetamine (MDMA) and metabolite correlation after controlled oral MDMA administration Behavioral effects and pharmacokinetics of (±)-3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) after intragastric administration to baboons Urinary excretion kinetics of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its phase I and phase II metabolites in humans following controlled MDMA administration.MDMA Impairs Response to Water Intake in Healthy Volunteers Further studies on the role of metabolites in (+/-)-3,4-methylenedioxymethamphetamine-induced serotonergic neurotoxicity.Effects of dose and route of administration on pharmacokinetics of (+ or -)-3,4-methylenedioxymethamphetamine in the rat Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA) and its pharmacodynamic consequences in the rat.Linear pharmacokinetics of 3,4-methylenedioxypyrovalerone (MDPV) and its metabolites in the rat: relationship to pharmacodynamic effects.Current status of hyphenated mass spectrometry in studies of the metabolism of drugs of abuse, including doping agents.Safety pharmacology of acute MDMA administration in healthy subjects.Altered Insula Connectivity under MDMA.Driving on ice: impaired driving skills in current methamphetamine users.Involvement of inferior parietal lobules in prospective memory impairment during acute MDMA (ecstasy) intoxication: an event-related fMRI study.Key interindividual determinants in MDMA pharmacodynamics.3,4-Methylenedioxymethamphetamine causes cytotoxicity on 661W cells through inducing macrophage polarization.Pharmacokinetic Profiles and Pharmacodynamic Effects for Methylone and Its Metabolites in Rats.Sex differences in 3,4-methylenedioxymethamphetamine (MDMA; ecstasy)-induced cytochrome P450 2D6 inhibition in humans.Pill content, dose and resulting plasma concentrations of 3,4-methylendioxymethamphetamine (MDMA) in recreational 'ecstasy' users.

P2860

Q22252794-39D94BE8-E5E0-4CAB-807B-07EBF390D713 Q24606265-47FCD09A-5CDC-4EBC-B154-910B8C0FC88C Q24658430-F0B85C49-E614-4BDF-81E4-3946593F5919 Q26859367-DB0A9084-5292-4033-914D-FBD9F0CDADC7 Q28484562-2D0B480F-379B-49C6-8081-85FA9ACE94DF Q33707843-0D092194-B179-4ABB-8F46-2C2C2827B6D8 Q34025177-F62E4075-BC28-4CFC-AC70-26BAF50C4284 Q34051713-1ABEB3A1-7C82-4B46-90CF-1A88A9353445 Q34243521-85484ECB-5C71-4E3F-8D42-2ECFA48ADD4F Q34391195-A11FF853-60FC-4FEC-B4A9-6A806B27886B Q34392399-6BC08B93-274B-4F5F-9496-461FAC165EF0 Q34423309-B86A1250-21BE-47A2-87BB-BCDCDE37CB69 Q34491601-B0FEADF6-7A02-43E1-8AAA-65EE37DF53DC Q35077922-5DAAEAEF-CDD8-4DEC-A3FB-E559C920C16C Q35154115-5B2330B3-3C7E-415B-BF52-E0F133E6B68F Q35175998-6771D59E-DFCE-45D5-A955-3E6F74F41EE1 Q35176011-0A0FF8F3-D6CD-4450-BFED-5095BF1F5F59 Q35228063-67FA5AF6-5B71-4837-8A95-A7D4C2C6CDC3 Q35635675-00BCC0F6-72B1-48BF-B63E-17CABD3349B8 Q35661148-40351F6D-F06C-450A-91EB-AACEE259B763 Q35823012-D3DBEF9C-9BF1-4BAD-AB42-A9BFDF03476E Q36800106-82EC1DBC-C662-4753-B602-D5A6C38EF17F Q36852604-17990D5A-346B-4B15-A115-4B912A143CEE Q37029550-567E2648-61AF-48DE-A916-62D500A3C0C6 Q37043838-D7FE80F1-7756-4069-8F5E-27D68CEFE132 Q37402744-1C076BE8-7EA3-4B0E-8FEB-EB877E27C9B4 Q37415781-E71251C6-4713-4752-8998-834293546913 Q37422671-490E9419-3169-4755-BBFD-A5651F00CF0F Q37716055-73073492-7B08-41B2-8C94-C787338A8D6C Q37922114-DDF6AD3D-D23D-4465-84D7-DF52884AFA79 Q38819567-2EC66F2E-8655-4E78-A32E-5119A5386A0E Q38962662-135C58FE-CE98-47E4-BA49-A6CC6AD3455A Q39578181-62935F65-FD05-4FC0-8365-D100F888FA2D Q43776592-8A0E6E75-8370-4764-9E66-E59D2459B550 Q47206849-F24FD9E3-683E-47BD-9CDA-13961EEE32B1 Q48029190-C5854793-57CE-44D3-AA02-A12A8CA11CD3 Q48459385-4A96285B-5E3C-4887-990E-0A5D97D0C2A5 Q51482811-C991EF0A-0F58-4063-A1A0-9821027A7CCC Q52298136-6FE33157-85D8-46E4-9E17-FA358182F85E

P2860

Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults.

http://www.wikidata.org/entity/Q37146495

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Plasma pharmacokinetics of 3,4 ...... dministration to young adults.

@en

Plasma pharmacokinetics of 3,4 ...... dministration to young adults.

@nl

type

label

Plasma pharmacokinetics of 3,4 ...... dministration to young adults.

@en

Plasma pharmacokinetics of 3,4 ...... dministration to young adults.

@nl

prefLabel

Plasma pharmacokinetics of 3,4 ...... dministration to young adults.

@en

Plasma pharmacokinetics of 3,4 ...... dministration to young adults.

@nl

P1433

Q37146495-7403FA06-3EC1-403D-85B0-37953BE56A93

P1476

Q37146495-74682798-900D-4B0D-9205-571499FA565B

P2093

Q37146495-2B91CBBA-5D3F-4A3F-8A95-26416991BBC6

Q37146495-5E4CE5F0-7707-4641-9880-E6E17DC282C8

Q37146495-63A3391F-8DB0-4391-9842-F7DE1D96584C

Q37146495-6E638B66-A027-40BF-AF9C-0A7852AB34DA

Q37146495-72D3EA3E-A95B-4675-A232-561506CBBF34

P2860

Q37146495-0892596E-B297-4A2A-8D34-54A1C8EE0ED5

Q37146495-0EA60F4F-F2C4-4E51-A0CA-2C30F85049BE

Q37146495-0FDF4DD4-E0AC-4D4D-B219-FCF975EDD07E

Q37146495-175DC740-83A2-41CC-B6DE-5B81CBA0B40E

Q37146495-1F41D6DD-80B4-4D37-A278-FCA20556D58A

Q37146495-26FDDD7D-C31A-456C-975F-E2E03A57EF65

Q37146495-30C70131-1120-446F-A03A-6B4A44CA0C36

Q37146495-32330823-EA27-444D-A93C-87065BA6442A

Q37146495-32BB6810-C204-4CFD-920E-E4229D8D72FB

Q37146495-369FED00-E295-4A46-B18C-704E227C0A3E

P304

Q37146495-55E53713-B500-4DCF-BFB3-4F0495B6FCC2

P31

Q37146495-AE16EE4B-1252-4FEA-9741-6AC731043997

P356

Q37146495-153320E7-0AE9-4DD1-A2A0-C7B55B652870

P433

Q37146495-CB109342-84D7-453C-9C39-F749076AC8CC

P478

Q37146495-42461745-D504-4B1D-9C05-A9D5392A76BF

P50

Q37146495-717A7F3A-B2CE-4D45-A0C3-617CE43BBFBC

P577

Q37146495-A4BCF94E-B66F-45C1-993A-5074D804B2D2

P698

Q37146495-3121749F-8366-4848-8463-0D52DC3A9AE2

P932

Q37146495-4C1FB271-5535-4214-A1B7-694AEACECD6E

P356

FTD.0B013E3181684FA0

P1433

Therapeutic Drug Monitoring

P1476

Plasma pharmacokinetics of 3,4 ...... dministration to young adults.

@en

P2093

David A Gorelick

http://www.w3.org/2001/XMLSchema#string

Elliot A Stein

http://www.w3.org/2001/XMLSchema#string

Erin A Kolbrich

http://www.w3.org/2001/XMLSchema#string

Robert J Hayes

http://www.w3.org/2001/XMLSchema#string

Robert S Goodwin

http://www.w3.org/2001/XMLSchema#string

P2860

Toxicokinetics of amphetamines: metabolism and toxicokinetic data of designer drugs, amphetamine, methamphetamine, and their N-alkyl derivatives.

A review of biological indicators of illicit drug use, practical considerations and clinical usefulness.

Stereospecific analysis and enantiomeric disposition of 3, 4-methylenedioxymethamphetamine (Ecstasy) in humans.

Human pharmacology of 3,4-methylenedioxymethamphetamine ("ecstasy"): psychomotor performance and subjective effects.

Gender differences in the subjective effects of MDMA.

Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition.

The evolution of drug metabolism.

An exploration of the history and controversies surrounding MDMA and MDA.

Ecstasy: dangers and controversies.

Non-linear pharmacokinetics of MDMA ('ecstasy') in humans

P304

320-332

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/FTD.0B013E3181684FA0

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P50

Marilyn Huestis

P577

2008-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18520604

http://www.w3.org/2001/XMLSchema#string

P932

2663855

http://www.w3.org/2001/XMLSchema#string